The Westin Diplomat
Hollywood, Florida

All registered attendees are invited to the Welcome Reception in the Exhibit Hall on Wednesday, March 13^th from 7:00 PM to 9:00 PM. The Annual Conference General Session begins on Thursday, March 14^th at 8:15 AM.

The following pre-conference programs will take place on Wednesday, March 13^th and will require separate registration:

2013 NCCN Nursing Program: Advancing Oncology Nursing™
Please note: This educational event has reached maximum capacity. All registrants from this point on will be placed on a wait-list and will be contacted if a seat becomes available. We encourage you to register and attend the main conference.

2013 NCCN Fellows Recognition Program: New Horizons in Quality Cancer Care™

NCCN Academy for Excellence & Leadership in Oncology™
School of Pharmaceutical & Biotech Business

Overview

AGENDA

Wednesday, March 13, 2013

7:00 – 9:00 PM
Registration and Welcome Reception

Thursday, March 14, 2013

7:00 – 8:00 AM
Breakfast and Exhibits

8:15 – 8:30 AM
Opening Remarks
Robert W. Carlson, MD
Chief Executive Officer
National Comprehensive Cancer Network

8:30 – 9:45 AM
*The Cost of Hope: A Candid Roundtable Discussion
Amanda Bennett, Pulitzer Prize-winning journalist
Executive Editor, Bloomberg News, and
Author, The Cost of Hope: A Memoir

Moderator: Sam Donaldson, ABC News veteran and anchor
Physician Panel: Ronald M. Bukowski, MD, Bukowski Consulting, LLC; Keith Flaherty, MD, Massachusetts General Hospital Cancer Center (Participating via Teleconference); J. Cameron Muir, MD, Executive Vice President, Quality & Access, Capital Caring and Assistant Professor of Oncology, Johns Hopkins Medicine; and Craig D. Turner, MD, Urologic Consultants, PC
Sponsored by Optum

Visit the NCCN Exhibit Hall for a Book Signing!
Sponsored by Xcenda, LLC

9:45 – 10:15 AM
Break, Exhibits, and General Poster Session I

10:15 – 11:15 AM
Systemic Therapy for Metastatic Colorectal Cancer
Leonard Saltz, MD
Memorial Sloan-Kettering Cancer Center

11:20 AM – 12:00 PM
New Developments in Thyroid Cancer
Robert I. Haddad, MD
Dana-Farber/Brigham and Women's Cancer Center

12:00 PM – 1:15 PM
Lunch, Exhibits, and General Poster Session I

1:15 – 2:30 PM
New Developments in the Management of Prostate Cancer
Philip W. Kantoff, MD
Dana-Farber/Brigham and Women's Cancer Center
James L. Mohler, MD
Roswell Park Cancer Institute

2:35 – 3:15 PM
New Treatment Guidelines for Penile Cancer
Philippe E. Spiess, MD
Moffitt Cancer Institute

3:15 – 3:45 PM
Break and Exhibits

3:45 – 5:00 PM
New NCCN Guidelines for Survivorship
Crystal S. Denlinger, MD
Fox Chase Cancer Center
Jennifer A. Ligibel, MD
Dana-Farber/Brigham and Women's Cancer Center

Friday, March 15, 2013

7:00 – 8:00 AM
Breakfast and Exhibits

8:15 – 9:30 AM
The Changing Oncology Landscape: Evolution or Revolution?
A Roundtable Discussion
Clifford Goodman, PhD (Moderator)
The Lewin Group

Panel: Roy Beveridge, MD, Chief Medical Officer, McKesson Specialty Health; John Fox, MD, MHA, Associate Vice President of Medical Affairs, Priority Health; Susan A. Higgins, MD, MS, Associate Professor, Department of Radiation Oncology, Yale University School of Medicine; Martin Kohn, MD, MS, Chief Medical Scientist, Care Delivery Systems, IBM Research; John J. "Jack" Mahoney, MD, MPH, Chief Medical Officer, Florida Health Care Coalition; Lee N. Newcomer, MD, MHA, Senior Vice President, Oncology, Genetics and Women's Health, UnitedHealthcare; Kavita Patel, MD, MSHS, Managing Director for Clinical Transformation and Delivery, The Brookings Institution Engelberg Center for Health Care Reform; and Andrew von Eschenbach, MD, President, Samaritan Health Initiatives

9:30 – 10:00 AM
Break, Exhibits, and General Poster Session II

10:00 – 10:50 AM
Updates in the Treatment of Bone Cancer
J. Sybil Biermann, MD
University of Michigan Comprehensive Cancer Center

11:00 AM – 12:00 PM
†Breakout Sessions – Round 1

Track 1: Distress Screening and the Integration of
Psychosocial Care into Routine Oncologic Care
Jimmie C. Holland, MD
Memorial Sloan-Kettering Cancer Center

Track 2: Communicating with Patients on Treatment
Options for Advanced Disease
Anthony Back, MD
University of Washington Medical Center
Lillie D Shockney, RN, BS, MAS
The Sidney Kimmel Comprehensive Cancer
Center at Johns Hopkins

Track 3: Management of Elderly Patients with Cancer
Arti Hurria, MD
City of Hope Comprehensive Cancer Center

Track 4: Management of Pain in Patients with Cancer
Robert A. Swarm, MD
Siteman Cancer Center at Barnes-Jewish Hospital and
Washington University School of Medicine

12:00 – 1:15 PM
Lunch, Exhibits, and General Poster Session II

1:15 – 2:15 PM
†Breakout Sessions – Round 2
Track 1: Distress Screening and the Integration of
Psychosocial Care into Routine Oncologic Care
Jimmie C. Holland, MD
Memorial Sloan-Kettering Cancer Center

Track 2: Communicating with Patients on Treatment
Options for Advanced Disease
Anthony Back, MD
Fred Hutchinson Cancer Research Center/
Seattle Cancer Care Alliance
Lillie D Shockney, RN, BS, MAS
The Sidney Kimmel Comprehensive Cancer
Center at Johns Hopkins

Track 3: Management of Elderly Patients with Cancer
Arti Hurria, MD
City of Hope Comprehensive Cancer Center

Track 4: Management of Pain in Patients with Cancer
Robert A. Swarm, MD
Siteman Cancer Center at Barnes-Jewish Hospital and
Washington University School of Medicine

2:25 – 3:25 PM
New Issues in Systemic Therapy for Ovarian Cancer
Deborah K. Armstrong, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

3:25 – 3:45 PM
Break and Exhibits

3:45 – 5:00 PM
Updates in the Treatment of Melanoma
Daniel G. Coit, MD
Memorial Sloan-Kettering Cancer Center
Anthony J. Olszanski, MD
Fox Chase Cancer Center

Saturday, March 16, 2013

7:00 – 8:00 AM
Breakfast

8:15 – 9:15 AM
Monitoring Response to TKI Therapy, Mutational Analysis,
and New Treatment Options in CML
Jerald P. Radich, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

9:20 – 10:20 AM
Risk Stratification and Emerging Treatments
in the Management of AML
Margaret R. O'Donnell, MD
City of Hope Comprehensive Cancer Center

10:20 – 10:45 AM
Break

10:45 AM – 12:00 PM
Recent Advances in the Treatment of NHL
Jeremy S. Abramson, MD
Massachusetts General Hospital Cancer Center
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center

12:00 – 1:15 PM
Lunch

1:15 – 2:15 PM
Therapeutic Advances in Relapsed/Refractory Multiple Myeloma
Kenneth C. Anderson, MD
Dana-Farber/Brigham and Women's Cancer Center

2:20 – 3:20 PM
Clinical Treatment Decisions for Advanced Renal Cell Cancer
Toni K. Choueiri, MD
Dana-Farber/Brigham and Women's Cancer Center

3:20 – 3:40 PM
Break

3:40 – 4:25 PM
‡Meet the Experts Breakout Session – Round 1

4:30 – 5:15 PM
‡Meet the Experts Breakout Session – Round 2

Sessions:
Breast Cancer
Richard L. Theriault, DO
The University of Texas MD Anderson Cancer Center

Colorectal Cancer
Al B. Benson III, MD
Robert H. Lurie Comprehensive Cancer Center
of Northwestern University

Lung Cancer
David S. Ettinger, MD
The Sidney Kimmel Comprehensive Cancer Center
at Johns Hopkins

Melanoma
Daniel G. Coit, MD
Memorial Sloan-Kettering Cancer Center

Multiple Myeloma
Kenneth C. Anderson, MD
Dana-Farber/Brigham and Women's Cancer Center

Psychosocial Care/Distress Management
Jimmie C. Holland, MD
Memorial Sloan-Kettering Cancer Center

Sunday, March 17, 2013

8:00 – 10:30 AM
Sunday Brunch with the Experts

(Option 1)
Breast Cancer: Advances in Risk Reduction, Treatment, and Survivorship
Therese B. Bevers, MD
The University of Texas MD Anderson Cancer Center
Lillie D. Shockney, RN, BS, MAS
The Sidney Kimmel Comprehensive Cancer Center
at Johns Hopkins
Richard L. Theriault, DO, MBA
The University of Texas MD Anderson Cancer Center

(Option 2)
Non-Small Cell Lung Cancer: Advances in Screening,
Treatment, and Survivorship
Rudy P. Lackner, MD
UNMC Eppley Cancer Center at The Nebraska Medical Center
Billy W. Loo, Jr., MD, PhD
Stanford Cancer Institute
Gregory A. Otterson, MD
The Ohio State University Comprehensive Cancer Center –
James Cancer Hospital and Solove Research Institute

Agenda subject to change.
* CME/CE credits are not available for this session
† Friday Breakout Sessions will occur twice. Attendees are able to attend one session each round.
‡Meet the Experts Breakout Sessions are limited to the first 50 attendees for each topic on a first-come, first-seated basis. Each session will be repeated once, giving the attendee the opportunity to attend two topics. These sessions are non-accredited.

The Cost of Hope: A Candid Roundtable Discussion Thursday, March 14, 2013 Amanda Bennett, Pulitzer Prize-winning journalist, executive editor at Bloomberg News, and author of The Cost of Hope: A Memoir, will begin the NCCN 18th Annual Conference with a moving and candid conversation about her late husband's battle with cancer and the costs incurred. She will be joined by a panel of oncologists. Sponsored by Optum Visit the NCCN Exhibit Hall for a Book Signing! Sponsored by Xcenda, LLC

The Changing Oncology Landscape: Evolution or Revolution? A Roundtable Discussion Friday, March 15, 2013 Clifford Goodman, PhD, of The Lewin Group, will moderate this panel which will address a variety of critical issues in oncology, including but not limited to, the impact of health reform, the shift in the site of oncology care, payer initiatives, and the role of pathways and technology.

Proceed for registration, accommodations, and complete program details!

Fee Information:
Register now and save $100. Early Bird Registration expires January 31, 2013. View complete registration fee information.

Accreditation Information:
This conference is approved for AMA PRA Category 1 Credit(s)™ for physicians and is also accredited for nurses, pharmacists, and other oncology professionals. View complete accreditation details.

Supporters:
This conference is supported by an educational donation provided by Amgen. This conference is supported by an independent educational grant from Abbvie. This conference is supported by educational grants from Astellas Scientific and Medical Affairs, Inc.; Bayer HealthCare and Onyx Pharmaceuticals, Inc.; Bristol-Myers Squibb; Celgene Corporation; Daiichi Sankyo, Inc.; Eisai Inc.; Genentech; Lilly USA, LLC.; Merck Sharp & Dohme Corp.; Millennium: The Takeda Oncology Company; Novartis Pharmaceuticals Corporation; Pfizer; Purdue Pharma L.P.; sanofi-aventis U.S. and Regeneron Pharmaceuticals; Sigma-Tau Pharmaceuticals, Inc.; Spectrum Pharmaceuticals, Inc.; and Teva Pharmaceuticals.

Airline Travel:
NCCN is proud to partner with American Airlines, Delta Air Lines, and United Airlines to offer attendees of the NCCN 18^th Annual Conference an opportunity to earn discounted airfares. Please view the detailed reservations and ticketing information for each carrier.

Car Rental:
Avis Rental Car is the preferred rental car supplier for the NCCN 18^th Annual Conference. View details for car rental.

Please check back often for the most up-to-date information. Please contact 866.788.NCCN (6226) or send an e-mail if you have additional questions.

Exhibitor Information

Organizations who are interested in exhibiting at NCCN programs are encouraged to contact Jennifer Tredwell, Director, Marketing.

NCCN 18^th Annual Conference Reimbursement Resource Room Application

NCCN 18^th Annual Conference Advertising Rate Card

NCCN 18^th Annual Conference Exhibit Application

Future NCCN Annual Conference Dates:

• Thursday, March 13, 2014 – Sunday, March 16, 2014
  Pre-conference programs take place on Wednesday, March 12, 2014
• Thursday, March 12, 2015 – Sunday, March 15, 2015
  Pre-conference programs take place on Wednesday, March 11, 2015